What's more, it addresses the FDA’s communications Using the applicant, the retention of information that support the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer possession of the SE report back to a new applicant and Digital submission from the SE report and am